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Abstract
Small cell lung cancer (SCLC) is an aggressive tumor, associated with ectopic ACTH syndrome.
We have shown that SCLC cells are glucocorticoid receptor (GR) deﬁcient, and that restoration of
GR expression confers glucocorticoid sensitivity and induces apoptosis in vitro. To determine the
effects of GR expression in vivo, we characterized a mouse SCLC xenograft model that secretes
ACTH precursor peptides,and sodriveshighcirculating corticosteroneconcentrations(analogous
to the ectopic ACTH syndrome). Infection of SCLC xenografts with GR-expressing adenovirus
signiﬁcantly slowed tumor growth compared with control virus infection. Time to fourfold initial
tumor volume increased from a median of 9 days to 16 days (PZ0.05; nZ7 per group). Post-
mortem analysis of GR-expressing tumors revealed a threefold increase in apoptotic (TUNEL
positive) cells (P!0.01). Infection with the GR-expressing adenovirus caused a signiﬁcant
reduction in Bcl-2 and Bcl-xL transcripts. Furthermore, in both the GR-expressing adenovirus-
infectedcellsandtumors,asigniﬁcantnumberofuninfectedcellsunderwentapoptosis,supporting
a bystander cell killing effect. Therefore, GR expression is pro-apoptotic for human SCLCs in vivo,
as well as in vitro, suggesting that loss of GR confers a survival advantage to SCLCs.
Endocrine-Related Cancer (2010) 17 203–213
Introduction
Lung cancer is the most frequently diagnosed major
cancer and the leading cause of cancer deaths world-
wide. Small cell lung cancer (SCLC) comprises 20% of
all lung cancers and is strongly associated with
cigarette smoking. It is the most aggressive of the
lung cancer subtypes and is generally disseminated at
the time of diagnosis. While it is initially responsive to
chemotherapy, the 5-year survival rate is !5% due
to relapse with chemoresistant disease, resulting in a
very poor prognosis (Jackman & Johnson 2005).
Even though considerable advances have been made
in the diagnosis and treatment of SCLCs over the past
10 years, long-term survival remains rare, and thus
novel approaches to treatment are demanded. SCLCs
are neuroendocrine carcinomas able to secrete a variety
of ectopic neuropeptides including the ACTH pre-
cursor, proopiomelanocortin. The ectopic secretion of
ACTH precursors by SCLCs has been shown to be
resistant to normal negative feedback inhibition by
circulating glucocorticoids (Gcs), which is evidence of
Gc resistance (White et al. 1990, White & Clark 1993).
Gcs are vital steroid hormones with wide-ranging
effects on cells and tissues, playing key roles in diverse
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Their action is mediated by the glucocorticoid receptor
(GR) which belongs to the nuclear receptor super-
family. The inability of Gcs to inhibit ACTH precursor
expression in SCLCs prompted investigation of GR
expression in SCLCs. We (Ray et al. 1996, Sommer
et al. 2007) and others (Hofmann et al. 1995) have
shown that SCLC cells contain negligible amounts of
functional GR, and hypothesized this to be the cause of
Gc resistance. The human GR is a transcription factor
that is expressed in virtually all cells and displays
genome-wide action, inﬂuencing around 20% of the
expressed genome (Donn et al. 2007). Activation by
Gc ligand results in transcriptional induction or
repression (Lu & Cidlowski 2006), and in addition,
the GR is able to mediate less well-characterized
non-genomic effects (Limbourg & Liao 2003,
Matthews et al. 2008). Gcs, acting through the GR,
have diverse effects on the survival of tissues and cell
types, but transcriptional regulation by the GR is
essential for life as GR
K/K mice die shortly after birth
(Reichardt et al. 1998).
Pertinent to this study, Gcs induce massive apoptosis
in lymphoid cells, and thus are used as for the treatment
of hematological malignancies. Despite being the
subject of much study, a canonical pathway for
GR-induced apoptosis has not been described and the
mechanisms may vary between cell types (Herr et al.
2007). The requirement for sufﬁcient levels of
functional GR to induce apoptosis has been demon-
strated in transgenic mice with increased or decreased
GR expression in human acute lymphoblastic leukemia
(T-ALL) cells expressing differing GR levels and in
Gc-resistant and Gc-sensitive multiple myeloma cells
(Schmidt et al. 2004). In GR
dim/dim mice, in which the
GR is unable to dimerize and therefore unable to bind
to DNA, normal Gc-induced thymocyte apoptosis does
not occur, suggesting that Gc-induced apoptosis
involves de novo gene expression (Reichardt et al.
1998). However, gene expression analysis has revealed
that some of the events leading to apoptosis may be
activated by the non-genomic actions of the GR
(Herr et al. 2007).
We have recently discovered that restoration of GR
expression in human SCLC cells in vitro powerfully
induces apoptosis (Sommer et al. 2007), suggesting
that loss of GR expression in SCLC cells promotes
their survival. Transgenic GR expression, which
induced apoptotic cell death in SCLC cells, also
upregulated pro-apoptotic genes of the Bcl-2 family
(Sommer et al. 2007). The Bcl-2 family of proteins
tightly regulates apoptosis, with damage signals being
transduced by the BH3-only proteins (tBid, Bad, Bim,
Noxa, and Puma) which interact with pro-survival
family members (Bcl-2, Bcl-xL, Bcl-w, A1, and
Mcl-1) to ablate their pro-survival function. This
ablation allows activation of Bax and Bak which
commit the cell to apoptosis (Adams & Cory 2007).
We have now extended our previous studies which
showed that GR over-expression kills human SCLC
cells in vitro, by assessing the impact of infecting
tumors in vivo with GR-expressing adenoviral vectors.
We now show that intratumoral injection of adenoviral
GR powerfully induces SCLC apoptosis in vivo.
Importantly, we found that GR over-expression caused
a signiﬁcant slowing in tumor growth, together with a
possible bystander effect. In contrast to in vitro ﬁndings
that GR over-expression upregulated the pro-apoptotic
genes, Bad and Bax (Sommer et al. 2007), in the
in vivo environment, GR over-expression downregu-
lated the pro-survival genes, Bcl-2 and Bcl-xL.
Materials and methods
Cell culture
DMS 79 cells (a gift from Prof. O Pettengill,
Dartmouth Medical School, Hanover, NH, USA)
were grown in RPMI-1640 medium containing
glutamax (Gibco) supplemented with 10% (FBS)
fetal bovine serum (Gibco) and 10 mM Hepes
(Gibco). A549 and human embryonic kidney (HEK)
293 cells (ECACC, Porton Down, Wilts, UK) were
cultured in DMEM (Gibco) containing glutamax
supplemented with 10% FBS.
Viral vector construction and propagation
The AdEasy Adenoviral Vector System (Stratagene,
La Jolla, CA, USA) was used to produce adenoviral
vectors carrying GR-eYFP and eYFP. Brieﬂy,
GR-eYFP and eYFP were excised from pFUNC1
GR-eYFP and pFUNC1 eYFP (Sommer et al. 2007)
using Not1 and were subcloned into pShuttle-CMV.
Successfully ligated pShuttle-CMV was linearized
with Pme1 and co-transformed with pAdEasy-1 super-
coiled vector into BJ5183 competent cells. Recombi-
nation of pAdEasy-1 and ligated pShuttle-CMV was
detected by Pac1 digestion. Recombinant adenoviral
plasmid was ampliﬁed by transformation into XL10-
gold cells. Linearized recombinant adenoviral plas-
mids were transfected into permissive HEK 293 cells
allowing homologous recombination and the gener-
ation of recombinant adenoviral vector particles. These
were tested for efﬁcacy by infecting A549 cells and
determining the expression of GR and eYFP by
real-time quantitative PCR. Large-scale preparations
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prepared and puriﬁed using the Adeno-X virus
puriﬁcation kit (Clontech) and the viral titer was
determined by plaque forming assays.
Adenoviral infection of A549 and DMS 79 cells
A549 and DMS 79 cells were infected at varying
multiplicities of infection (MOIs: equivalent to plaque
forming units/tumor cell). A549 cells grow as a
monolayer and were infected by the addition of virus
at MOIs of 10, 50, and 100 to the medium. DMS 79
cells grow as spheroids in suspension and so were
transduced by spinning cells and virus at 2000 g for 2 h
on two consecutive days in the presence of 8 mg/ml
polybrene (Sigma).
Flow cytometry
DMS 79 cells at a density of 3–4!10
6 cells/ml were
d r a w nu pt h r o u g ha0 . 4 m m !12 mm needle and
expelled through a 40-mm cell strainer into PBS (BD
Falcon, Le Pont declaix, France) to create a single cell
suspension. Cells were analyzed for eYFP ﬂuorescence
(530/40 nm; infected cells) on a DakoCytomation
Cyan ﬂow cytometer using Summit software (Dako-
Cytomation, Ely, UK). To determine viability, cells
were stained with propidium iodide (PI) and gated to
determine the percentage of eYFP- and PI-positive
cells. For the apoptosis assays, the pelleted cells were
resuspended in buffer (10 mM Hepes, 10 mM NaOH,
140 mM NaCl, and 25 mM CaCl2), strained, incubated
with 5-ml human recombinant APC-conjugated
Annexin V (Bender MedSystems, Vienna, Austria)
at room temperature for 15 min, and analyzed at
665/20 nm. To determine the percentage of eYFP-and
Annexin V-positive cells, 10 000 cells were gated.
Xenograft studies
Low-passage number DMS 79 cells were grown to
logarithmic phase. The cell concentration was adjusted
to 1!10
8 cells/ml in serum-free RPMI-1640 medium
and diluted to 5!10
7 cells/ml with the addition
of matrigel (1:1; BD Biosciences, Cowley, UK).
Xenografts were established by the s.c. injection of
DMS79 cells (0.1 ml, 5!10
7DMS 79 cells in matrigel
(1:1)) on the backs offemale cba nu/nu mice. Once the
tumors were established, measurements were made
every 2–3 days using calipers. When the tumor
size reached 180–200 mm
3,5 !10
8 pfu of control
(Ad-eYFP) or Ad-GR-eYFP virus was delivered by
intratumoral injection into the center of the tumor.
For the ﬁrst experiment (nZ6 per group), the tumors
were excised 72 h after the initial injection and snap
frozen. The spleen, kidneys, and adrenals were
removed and placed into formalin ﬁxative. The liver
was snap frozen and the blood was collected.
For the growth delay experiment (nZ7 per group),
the virus was administered when the tumors reached
180–200 mm
3 in size, and twice thereafter at 4-day
intervals. Tumor size was measured daily using
calipers until their sizes reached four times the initial
treatment size (RTV4), whereupon the tumors were
harvested as described. Tumor growth delay was
measured by plotting the average tumor size and
S.E.M. per day. The time taken for each tumor to reach
RTV4 was calculated, and the data were log
transformed to overcome the non-parametric data and
subjected to a two-tailed t-test.
All procedures were carried out using approved
protocols (Home Ofﬁce Project License 4002328) in
accordance with the Scientiﬁc Procedures Act 1986
and in line with the United Kingdom Co-ordinating
Committee on Cancer Research Guidelines on the
welfare of animals in experimental neoplasia
(Workman et al. 1988).
ACTH precursor and corticosterone assays
ACTH precursors were measured using a speciﬁc
two-site ELISA based on an IRMA format described
previously (Crosby et al. 1988). Corticosterone was
measured using an ELISA with a sensitivity of
0.17 ng/ml (IDS Ltd).
Immunohistochemistry
Eight-micrometer tumor cryosections were ﬁxed in
4% paraformaldehyde (PFA) for 15 min at room
temperature. The sections were washed with PBS,
permeabilized with 0.1% Triton X-100 in 0.1% sodium
citrate in water for 2 min, washed with PBS, and
blocked with 10% horse serum in PBS for 1.5 h at
room temperature. To detect the presence of virus
using eYFP, rabbit polyclonal green ﬂuorescent
protein (GFP) antibody (Invitrogen, 1:2000) was
added to the sections at 4 8C overnight. The sections
were then washed and incubated in FITC-labeled
secondary anti-rabbit (Invitrogen, 1:500) for 1.5 h,
following which, the sections were washed with PBS
and mounted using hard set mounting medium
containing 4’ ,6-diamidino-2-phenylindole (DAPI)
(Vector Labs). For co-localization with TUNEL
staining, TUNEL reagent (TMR Red, Roche,
Peterborough, UK) was added with the secondary
antibody for 1.5 h in the dark at room temperature.
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manufacturer’s instructions. The images were captured
on a Leica SP2 AOBS confocal microscope. The
ﬂuorescence intensity of TUNEL and GFP staining in
ten sections was enumerated using Image J, and is
presented as a ratio of TUNEL/GFP.
Quantitative PCR
Seventy-two hours post infection, RNA was extracted
from DMS 79, A549, and HEK 293 cells spinfected or
infected with GR-eYFP or eYFP viruses (RNeasy kit,
Qiagen) as well as from tumors injected with Ad-eYFP
or Ad-GR-eYFP (TriReagent, Sigma). After DNAse 1
treatment (Promega), cDNA was synthesized using
Superscript 111 (Invitrogen) and Oligo-dT primers
(Invitrogen). Quantitative PCR was performed using
SYBR Green JumpStart Taq ready mix (Sigma) as per
the manufacturer’s instructions. Results were
analyzed using the 2K DDCt method relative to GAPDH
expression (Livak & Schmittgen 2001). Primer
sequences are as follows: Bcl-2 (NM_000633.2)
F5 0-CCCTCCAGATAGCTCATT-30,R5 0-CTAGA-
CAGACAAGGAAAG-30; Bcl-xL (NM_001191.2)
F5 0-ATCAATGGCAACCCATCCTG-30,R5 0-TTGT-
CTACGCTTTCCACGCA-30; Bin EL (NM_138621.3)
F5 0-GCCACCTGCCAGC-30,R5 0-ACAGCAGGGA-
GGATCTTCTCATAA-30; GAPDH (NM_000012)
F5 0-GAAGGTGAAGGTCGGAGT-30,R5 0-GAAGA-
TGGTGATGGGATTTC-30;G R a (NM_000176)
F5 0-CCATTGTCAAGAGGGAAGGA-30,R5 0-CAG-
CTAACATCTCGGGGAGGAAT-30;a n de Y F P
F5 0-TGCTTCAGCCGCTACCCCGACC-30,R5 0-CG-
CCGATGGGGGTGTTCTGCTG-30.
To determine the number of successfully transfected
cells per tumor, the number of eYFP transcripts in
each tumor was calculated relative to eYFP expression
in HEK where 100% of the cells were infected
(as determined microscopically and by ﬂow cytome-
try). Quantitative PCR was performed using primers
for eYFP and GAPDH on tumor cDNA and HEK
cDNA. The fold change in eYFP transcripts relative to
GAPDH was calculated using the 2K DDCt method, and
the data were changed to a percentage.
Statistical analysis
As the data on tumor growth were not normally
distributed, they were log transformed and then
comparisons were made using Student’s t-test, two-
tailed for independent samples. ACTH precursors and
qRT-PCR were compared using an unpaired Student’s
t-test. Analyses were run using SPSS.
Results
SCLC xenografts
DMS 79 cells were used for xenograft generation
because they secrete ACTH precursor peptides
(a frequent clinical feature of human SCLCs),
providing a potential biomarker for tumor presence
or mass (White et al. 1990). DMS 79 cell xenografts
exhibited typical SCLC pathology, and the mice had
marked increases in circulating ACTH precursor
concentrations (Fig. 1A and B). This was accompanied
by adrenal cortical hyperplasia (data not shown).
Engrafted mice also had raised corticosterone concen-
trations (180 ng/mlG64.5 for Ad-eYFP-injected
tumors and 186 ng/mlG40 for Ad-GR-eYFP-injected
tumors compared to 85.4 ng/mlG16.5 in non-
engrafted animals), as predicted from the raised
ACTH peptide concentrations, providing an accurate
model of the ectopic ACTH syndrome.
Development of adenoviral vectors for GR-eYFP
and eYFP
Previously, we had shown that retrovirally mediated
over-expression of GR-eYFP in SCLC cell lines
in vitro resulted in apoptotic cell death when compared
with the effects of a control virus expressing eYFP
alone (Sommer et al. 2007). However, effects on pure
cell populations in vitro may not translate into the
complex environment of a solid tumor, with vascular
and cell matrix components inﬂuencing the tumor
cells. Therefore, to determine what effect GR
expression had on tumors, GR-eYFP and eYFP were
cloned into adenoviral expression vectors to increase
infection efﬁciency in vivo.
A549 and DMS 79 cells were infected with
adenoviruses expressing eYFP alone or GR-eYFP at
MOIs of 10, 50. and 100. Infection at all MOIs
showed a signiﬁcant upregulation of GR expression
in all cells infected with Ad-GR-eYFP (Fig. 1C,
MOIZ50). In the A549 cells, which are readily
infected by adenovirus, a 1200-fold increase in GR
expression was achieved. DMS 79 cells grow as
spheroids in suspension and are notoriously difﬁcult to
transfect; however, infection with the GR-expressing
adenovirus still resulted in a 400-fold increase in
GR expression (Fig. 1C )a n di na ni n f e c t i o n
efﬁciency O30%, as estimated using a simple eYFP-
expressing adenovirus, a more reliable marker of
infection as GR over-expression results in cell death
(Fig. 1D).
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resulted in apoptotic death of infected
cells in vivo
When SCLC xenografts reached 180–200 mm
3 in size,
the tumors were injected with Ad-eYFP or
Ad-GR-eYFP and were excised 72 h later (nZ6 per
group). As the eYFP ﬂuorescence in the 8-mm sections
was faint, the presence of eYFP was detected using an
antibody. SCLC xenografts were successfully infected
with the adenoviral vectors (Fig. 2A). There were more
apoptotic cells, and a higher ratio of TUNEL-positive
to eYFP-positive cells in tumors infected with the
Ad-GR-eYFP adenovirus compared with tumors
infected with the control virus, Ad-eYFP (Fig. 2A
and B). PBS injection had no effect on apoptosis, and
as expected, the resulting tumors were negative for
eYFP expression (Fig. 2A).
As adenoviral delivery of transgenes is a relatively
inefﬁcient process (Krasnykh et al.2 0 0 0 )w h i c h
depends upon viral diffusion from the injection site,
we estimated the number of successfully infected cells/
tumor by enumerating the number of eYFP transcripts/
tumor. RNA was extracted from tumors infected with
control and Ad-GR-eYFP viruses. eYFP transcripts
were ampliﬁed using real-time quantitative PCR and
compared with eYFP expression in the HEK cell line
(relative to GAPDH expression), where 100% of the
cells were infected with the virus. There were
consistently fewer eYFP-positive cells seen in tumors
after GR-eYFP infection, probably due to death of
infected cells (Fig. 2C).
Ad-GR-eYFP infection of SCLC xenografts in
nude mice causes tumor growth delay
The in vivo effects of GR expression on the growth of
the SCLC tumors were determined by injecting the
GR-eYFP- and control eYFP-expressing adenoviral
constructs when the established tumors had reached
180–200 mm
3 in size. Thereafter,the tumorsweregiven
twomoreinjectionsat4-dayintervalsandwereharvested
when the tumor volume had quadrupled (RTV4). Over-
expression of the GR delayed tumor growth by 1 week
(tumorsinfectedwithAd-eYFPtook9daystoquadruple
in size, whereas tumors infected with Ad-GR-eYFP
took 16 days) (tZ2.131, dfZ12, PZ0.05) (nZ7)
(Fig. 3A and B). The wet weights of the adrenal glands,
spleen, and kidneys were not changed (data not shown).
There was continuing expression of the viral
transgenes at tumor harvest, but the proportion of
eYFP-positive cells was lower after the injection of
Ad-GR-eYFP than after the injection of Ad-eYFP
alone, which was compatible with the loss of
Figure 1 Development of SCLC xenografts in nude mice and
functional testing of adenoviral vectors expressing GR-eYFP or
eYFP. (A) SCLC xenografts were created by the s.c. injection of
DMS 79 cells in matrigel. The SCLC xenografts displayed
pathology that was similar to that of human SCLCs with large
areas of necrosis (yellow arrow) and oval nuclei with scant
cytoplasm (white arrow). (B) In addition, these tumors secreted
ACTH precursors into the circulation at a higher level than
non-SCLC human colon carcinoma xenografts (HCT116 cells;
nZ3, *P!0.05). (C) Infection of A549 and DMS 79 cells with
Ad-GR-eYFP resulted in a signiﬁcant upregulation of GR
expressionwhencomparedwith GR expressionin cellsinfected
with the control virus, Ad-eYFP (MOIZ50; *P!0.05). (D) DMS
79 cells were spinfected with Ad-eYFP or Ad-GR-eYFP, and
after 72 h, the percentage of infected (eYFP Cve) cells in each
population was determined by FACS.
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relatively fewer GR-eYFP-positive cells being ident-
iﬁed in tumor sections, over-expression of the GR
caused a delay in tumor growth, suggesting a
biologically important effect.
Ad-GR-eYFP infection of SCLC xenografts in
nude mice induces tumor cell apoptosis
To investigate the effect of GR expression on growth
rate, tumor sections were analyzed by TUNEL
staining. There was evidence of a greatly increased
rate of apoptosis in tumors infected with Ad-GR-eYFP
compared with the Ad-eYFP control (Fig. 3D and E).
A clear increase in the amount of TUNEL staining is
seen in tumors injected with Ad-GR-eYFP (Fig. 3E)
when compared with Ad-eYFP-injected xenografts
(Fig. 3D) quantiﬁed in Fig. 3F.
Ad-GR-eYFP infection of SCLC xenografts also
results in apoptosis of uninfected tumor cells: a
bystander effect?
The increased TUNEL staining in both infected and
uninfected cells in tumors injected with Ad-GR-eYFP
coupled with the signiﬁcant growth delay despite
relativelylowinfectionratespromptedustoinvestigate
apoptosis in vitro in uninfected SCLC cells in mixed
populations with infected Ad-GR-eYFP-expressing
cells. Over-expression of GR by adenoviral infection
caused the death of infected SCLC cells (yellow arrow)
when compared with cells infected with control virus
(Fig. 4A and B), which is an effect similar to that seen
with retroviral gene delivery (Sommer et al. 2007).
Interestingly, there is also a clear shift in the population
of non-GR-eYFP-positive SCLC cells toward cell
death (black arrow; Fig. 4B). We showed that there
was a signiﬁcant increase in cell death (Fig. 4C) and
apoptosis (Fig. 4D) in non-GR-expressing cells derived
from infected populations when quantiﬁed.
The same effect is seen in vivo where there was
clearly more apoptosis in uninfected cells in xenografts
exposed to Ad-GR-eYFP than in those exposed to the
control, Ad-eYFP (Fig. 4E–G). The evidence suggests
a bystander effect, whereby GR-induced cell death
transmits a pro-apoptotic signal to non-expressing
SCLC cells.
Ad-GR-eYFP infection of SCLC xenografts affects
expression of pro-survival and pro-apoptotic
genes
Previously, we had shown that, in vitro,o v e r -
expression of the GR caused a signiﬁcant upregulation
Figure 2 Ad-GR-eYFP infection of established SCLC xeno-
grafts resulted in apoptosis. (A) SCLC xenografts were injected
with Ad-eYFP or Ad-GR-eYFP when the tumors reached 180–
200 mm
3 in size (nZ6 per group). After 72 h, the tumors were
harvested. Cryosections were stained with anti-GFP (Invi-
trogen) to detect the presence of virus and with TUNEL-TMR
(red; Roche) to detect apoptotic cells and were examined by
confocal microscopy. No GFP or TUNEL staining was seen in
tumors injected with PBS. GFP staining revealed cells infected
with Ad-eYFP or Ad-GR-eYFP (white arrows), while apoptotic
cells were revealed by TUNEL staining (*). Co-staining with
GFP and TUNEL was clearly seen in Ad-GR-eYFP-infected
cells only (yellow arrows). The two Ad-GR-eYFP panels
represent two different ﬁelds for the same experimental
conditions. (B) The total GFP and TUNEL ﬂuorescence of ten
different sections for each treatment was quantiﬁed using
Image J software and is displayed as a ratio of TUNEL/GFP.
Cells infected with Ad-GR-eYFP displayed signiﬁcantly more
TUNEL staining than cells infected with the control virus,
Ad-eYFP (*P!0.05). (C) The percentage of eYFP-positive cells
remaining in the tumors after 72 h was determined by real-time
quantitative PCR and compared with eYFP expression in HEK
cells, where 100% of the cells express eYFP.
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resulted in apoptosis of the SCLC cell lines. Here,
we show that the tumor microenvironment has a
signiﬁcant effect on gene expression. Bad (Fig. 5A)
and Bim (Fig. 5B) are over-expressed in DMS 79
xenografts when compared with expression proﬁles
in vitro. However, the expression of Bad in vivo is
unaffected by GR over-expression. Bax levels are
similar in vivo and in vitro and are unaffected by GR
over-expression in vivo (Fig. 5C). Most notably, we
showed that while DMS 79 cells express low levels of
the pro-survival genes, Bcl-2 and Bcl-xL in vitro
(Fig. 5D and E), in the tumor microenvironment,
the expression of Bcl-2 and Bcl-xL is dramatically
upregulated and signiﬁcantly repressed by over-
expression of the GR.
Discussion
We have used a human SCLC xenograft model of lung
cancer to analyze the effect of GR expression on tumor
behavior. We have shown that over-expression of GR
in these SCLC xenografts leads to apoptotic cell death
associated with downregulation of the pro-survival
genes, Bcl-2 and Bcl-xL, and results in delayed tumor
growth in vivo.
Figure 3 Infection of tumor cells with Ad-GR-eYFP caused growth delay. (A) When SCLC xenografts reached 180–200 mm
3 in size,
the tumors were injected with either Ad-eYFP or Ad-GR-eYFP, three times at 4-day intervals (nZ7 per treatment). Tumor growth
was measured daily using calipers and the tumors were excised when the relative tumor volume reached four times the initial
injection size. (B) Restored GR expression signiﬁcantly (PZ0.05) slowed tumor growth to four times the initial treatment size by 1
week. (C) To determine the number of infected cells per tumor, qPCR was used to determine the number of eYFP transcripts from
three tumors. The percentage of eYFP-positive cells in the tumors at harvest was compared with eYFP expression in HEK cells,
where100%ofthecellsexpresseYFPrelativetoGAPDHexpression.GrowthdelaycausedbyAd-GR-eYFPismediatedbyincreased
apoptosis. (D–F) Cryosections were stained with anti-GFP (Invitrogen) to detect the presence of virus and with TUNEL-TMR (red;
Roche) to detectapoptoticcells and wereexaminedbyconfocalmicroscopy.Although Ad-eYFPwas effectivein infectingtumor cells
(whitearrows)(D),fewTUNEL-positivetumorcellswereseenintherepresentativesectionsshown.However,tumorcellsinfectedwith
Ad-GR-eYFP also stained positive with TUNEL (E) (yellow arrows). (F) The total GFP and TUNEL ﬂuorescence of ten different
sections for each treatment was quantiﬁed using Image J software and is displayed as a ratio of TUNEL/GFP. Cells infected with
Ad-GR-eYFP displayed signiﬁcantly more TUNEL staining than cells infected with the control virus, Ad-eYFP (*P!0.05).
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(DMS 79) used to create the xenograft model
expressed very low levels of the GR, and that
restoration of GR expression in the cells by transfec-
tion inhibited the secretion of ACTH precursors from
the cells in culture (Sommer et al. 2007). In this study,
we found that tumors formed from DMS 79 cells also
secreted ACTH precursor peptides. The excess ACTH
precursor peptides in the circulation mimicked the
ectopic ACTH syndrome and resulted in hyperplasia of
the corticosterone-producing cells in the zona
fasciculata of the adrenal cortex, as expected, but
there was no signiﬁcant change in adrenal wet weight,
possibly reﬂecting the relatively short exposure of the
adrenal glands to ACTH drive. Restoration of GR
expression by infection of Ad-GR-eYFP in the
xenografts did not inhibit plasma ACTH precursor
peptides or circulating corticosterone. This may reﬂect
the protocol design, given that samples were not
collected until the tumor was removed, which was
done at a time when tumor burden (w800 mm
3)
was similar in the eYFP and GR-eYFP groups.
Figure 4 Apoptosis in DMS 79 cells and xenografts infected with Ad-GR-eYFP. In vitro: DMS 79 cells were infected with adenovirus.
After 72 h, the cells were stained with PI and Annexin V and analyzed by ﬂow cytometry. There is a clear shift in the Ad-GR-eYFP-
infected population toward a dead or dying state (yellow arrow) (B) compared with the control virus-infected cells (A). There is also a
similar shift in non-GR-eYFP-expressing cells (black arrow) (B). Ad-eYFP serves as a control where no such shift is seen (A). The
proportionofuninfected(eYFPKve)cells,drawnfromthesamepopulationsdescribedabove,whicharePICve(C)andAnnVCveis
shown(D).InCandD,amean(GS.D.)ofthreeseparateexperimentsisshown(*P!0.05,comparedwitheYFPcontrol).Invivo:tumor
cryosections were stained with anti-GFP (Invitrogen) to detect the presence of virus and with TUNEL-TMR (red; Roche) to detect
apoptotic cells and were examined by confocal microscopy. Ad-eYFP- and Ad-GR-eYFP-infected cells can be seen clearly (white
arrows,EandFrespectively).LittleornoTUNELstainingisseenintheAd-eYFP-injectedxenograft.However,TUNELstainingisclearly
visibleinnon-GR-eYFP-expressingcellsintheAd-GR-eYFP-infectedtumor(yellowarrows,F).(G)TheamountofTUNELﬂuorescence
in ten different sections from three different Ad-eYFP and Ad-GR-eYFP was quantiﬁed using Image J software (*P!0.05).
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corticosterone in all SCLC xenograft-bearing animals
capable of activating the transgenic GR.
Ad-eYFP and Ad-GR-eYFP were shown to infect
tumor cells by immunostaining for the presence of
eYFP. Infection with Ad-GR-eYFP resulted in
apoptotic death of the SCLC tumor cells as evidenced
by TUNEL assay. Mitochondrial apoptosis is regulated
via a balance between the BH3-only pro-apoptotic
proteins (such as Bad, Bim, Bid, Noxa, and Puma) and
the pro-survival proteins (such as Bcl-2 and Bcl-xL).
Cell survival is promoted by elevated levels of pro-
survival proteins such as Bcl-2 and Bcl-xL, which
prevent Bax-mediated perturbation of the mito-
chondrial membrane (Adams & Cory 2007) and thus
inhibit apoptosis. Resistance to therapy in multiple
cancers is associated with over-expression of Bcl-2 and
Bcl-xL (Olejniczak et al. 2007, Schwartz et al. 2007).
Bcl-2 is over-expressed in 75% of the SCLCs (Pisick
et al. 2003), and its locus is ampliﬁed in 48% of the
patients (Olejniczak et al. 2007). While the Bcl-2 locus
in the DMS 79 cells used to create the xenografts is
not ampliﬁed (Olejniczak et al. 2007), we found that
the tumors over-expressed Bcl-2 as well as Bcl-xL,
Bad, and Bim in comparison to transcript levels
in vitro, while Bax levels remained unchanged. Most
notably, over-expression of GR by adenoviral infection
in these tumors signiﬁcantly inhibited Bcl-2 and
Bcl-xL transcript abundance. These results are similar
to those in the juvenile rat hippocampus, where
dexamethasone has been shown to downregulate Bcl-2
andBcl-xLandupregulateBax(Sandau&Handa2007),
while downregulation of Bcl-2 expression is thought
to contribute to Gc-induced apoptosis in U2-OS cells
(Rogatsky et al. 1999, Lu et al. 2007). The mechanism
whereby the GR regulates these genes remains unclear.
Analysis of the promoter region and 5 kb upstream
revealed potential GR binding sites in Bcl-xL but not in
Bcl-2 (MatInspector, Genomatix, www.genomatix.de).
These results differ from our in vitro ﬁndings where
over-expression of the GR increased Bad and Bax
transcript abundance, suggesting that over-expression
Figure 5 Expression levels of pro-survival and pro-apoptotic
genes in tumors injected with Ad-eYFP and Ad-GR-eYFP.
Seventy-two hours post infection, RNA was extracted from
DMS 79, A549, and HEK 293 cells spinfected or infected with
Ad-GR-eYFP or Ad-eYFP viruses as well as from tumors
injected with Ad-eYFP or Ad-GR-eYFP. cDNA was synthesized
and subjected to real-time quantitative PCR. The relative
expression levels of Bad (A), Bim (B), Bax (C), Bcl-2 (D), and
Bcl-xL (E) are shown. Data were analyzed using the 2K DDCt
method relative to GAPDH expression (*P!0.05; comparisons
are shown with horizontal bars; nZ3).
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in vitro and in vivo; however, the pro-apoptotic
rheostat is activated in vitro, while the pro-survival
rheostat is suppressed in vivo, illustrating the effect of
the tumor microenvironment on gene expression. Here,
we suggest that GR-mediated inhibition of Bcl-2 and
Bcl-xL would relieve repression of Bax activity and
thus trigger the apoptotic cascade, thereby slowing
tumor growth. This effect has been shown previously
where small molecule inhibitors of pro-survival
proteins such as ABT-737 improved survival and
caused tumor regression in mice (Oltersdorf et al.
2005, Tahir et al. 2007).
A major limitation of gene delivery using adenoviral
vectors is the inability to transduce all the tumor cells
in vivo. In this study, we have shown that only 8% of
the tumor cells express the eYFP transgene, yet
signiﬁcant growth delay and changes in gene
expression occur. Examination of sections of infected
tumors revealed TUNEL staining in uninfected cells.
These cells may have had low level expression of the
transgene, or may have lost transgene expression after
committing to the apoptotic program. However, the
frequency of apoptotic cells in Ad-GR-eYFP-injected
tumors is greater than the predicted frequency of
transgene-expressing cells, based on the experiments
with the Ad-eYFP-injected tumors. Indeed, both
retroviral delivery of GR (Sommer et al. 2007) and
adenoviral delivery to SCLC cells in vitro resulted
in a striking excess of apoptotic cells compared with
the number found to be expressing the transgene.
As the number of dying cells seen in GR-eYFP-
infected cell cultures is greater than the number of
cells estimated to be infected (eYFP positive after
eYFP adenoviral infection), this supports a bystander
cell kill effect.
Bystander killing plays a crucial role in cancer
therapy as it signiﬁcantly ampliﬁes the anti-tumor
effect of cytotoxic therapy (Hyer et al. 2003). This has
been observed in response to u.v. radiation, photo-
dynamic therapy, and chemotherapeutic agents in
diverse cell types such as lymphocytes, ﬁbroblasts,
endothelial cells, and tumor cells. Despite the
importance of this phenomenon, the mechanisms that
are responsible are poorly deﬁned (Prise & O’Sullivan
2009). In vitro analysis suggests two mechanisms. For
cells in direct contact, small molecules, including
secondary messengers, can transmit apoptotic signals
through gap junctions. Alternatively, the release of
‘death’ signals into the extracellular ﬂuid may
stimulate cells not in direct contact to undergo
apoptosis. The latter mechanism is well documented
in response to radiation, but the nature of the signal(s)
remains unknown (Prise & O’Sullivan 2009).
Recently, mitochondria-mediated apoptosis has been
shown to be able to induce a bystander effect in vitro
whereby signals are transduced to neighboring cells via
gap junctions, although again the nature of the signal
has not been elucidated (Peixoto et al.2 00 9 ). Thus, it is
possible that the bystander apoptosis seen in this study
is mediated by transmission of apoptotic signals
through gap junctions. However, it is clear that
bystander responses are more complex, and harder to
deﬁne in tumors grown in vivo (Prise & O’Sullivan
2009). Therefore, in our current study, which relies on
solid tumor growth, both diffusion and gap junction
mechanisms may play a role.
In conclusion, we report that over-expression of the
GR in SCLC xenografts causes apoptotic death of
the SCLC cells in tumor grafts by downregulation
of pro-survival genes and thus signiﬁcantly delays
tumor growth. The pro-apoptotic effect of restored
GR expression in SCLC cells in vitro and now in vivo
is a novel and exciting ﬁnding, and a deeper
understanding of the mechanism whereby GR
causes apoptosis in these cells offers a great promise
for developing more selective and efﬁcacious thera-
peutic agents.
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